fennecpharma.com
FENNEC ANNOUNCES THE LANCET ONCOLOGY PUBLICATION OF CHILDREN’S ONCOLOGY GROUP STUDY OF SODIUM THIOSULFATE | Fennec Pharmaceuticals
Research Triangle Park, NC, December 1, 2016 – Fennec Pharmaceuticals Inc. (TSX: FRX, OTCQB: FENCF), a specialty pharmaceutical company focused on the